MVM Life Science Partners — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Optinose is a specialty pharmaceutical company that develops and markets products for patients with conditions treated by ear, nose, and throat (ENT) and allergy specialists.
BiotechHealthtechMedical DevicesYardley, US
Per Djupesland(Executive Officer, Director)Michele Janis(Executive Officer)Peter Miller(Executive Officer, Director)Terrence Terifay(Executive Officer)Ramy Mahmoud(Executive Officer)
BoardKlaas De Boer(Director)
Board seatEric BednarskiKyle Dempsey· per SEC Form D · $4.7M raise · filed May 2024
Co-investorsForesite Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.